Long‐term outcome of liver resection for colorectal metastases in the presence of extrahepatic disease: A multi‐institutional Japanese study

The purpose of the present study was to assess long‐term outcomes following liver resection for colorectal liver metastases (CRLM) with concurrent extrahepatic disease and to identify the preoperative prognostic factors for selection of operative candidates.

[1]  U. Güller,et al.  Population-based SEER analysis of survival in colorectal cancer patients with or without resection of lung and liver metastases , 2020, BMC Cancer.

[2]  B. Isaksson,et al.  Liver resection is beneficial for patients with colorectal liver metastases and extrahepatic disease. , 2020, Annals of translational medicine.

[3]  G. Honda,et al.  Comprehensive data of 3,525 patients newly diagnosed with colorectal liver metastasis between 2013 and 2014: 2nd report of a nationwide survey in Japan. , 2018, Journal of hepato-biliary-pancreatic sciences.

[4]  M. Dillhoff,et al.  A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients. , 2019, Annals of surgery.

[5]  G. Honda,et al.  Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases—a Japanese Nationwide Survey , 2019, Journal of Gastrointestinal Surgery.

[6]  Tsuyoshi Saito,et al.  Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan , 2018, Japanese journal of clinical oncology.

[7]  Yuhree Kim,et al.  Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases , 2018, The British journal of surgery.

[8]  H. Matsumoto,et al.  Clinicopathological and molecular differences between right-sided and left-sided colorectal cancer in Japanese patients , 2018, Japanese journal of clinical oncology.

[9]  G. Honda,et al.  Comprehensive data of 3,820 patients newly diagnosed with colorectal liver metastasis between 2005 and 2007: report of a nationwide survey in Japan , 2018, Journal of hepato-biliary-pancreatic sciences.

[10]  Masahiro Yoshida,et al.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer , 2012, International Journal of Clinical Oncology.

[11]  K. Muro.  Systemic chemotherapy for metastatic colorectal cancer -Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2016 for treatment of colorectal cancer. , 2017, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[12]  J. Samra,et al.  Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes. , 2016, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[13]  M. Gönen,et al.  Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection , 2016, Annals of surgery.

[14]  P. Majno,et al.  Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases , 2015, The British journal of surgery.

[15]  G. Honda,et al.  A nomogram predicting disease-free survival in patients with colorectal liver metastases treated with hepatic resection: multicenter data collection as a Project Study for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery , 2012, Journal of hepato-biliary-pancreatic sciences.

[16]  E. Vibert,et al.  Concomitant Extrahepatic Disease in Patients With Colorectal Liver Metastases: When Is There a Place for Surgery? , 2011, Annals of surgery.

[17]  M. Choti,et al.  Liver Resection for Colorectal Metastases in Presence of Extrahepatic Disease: Results from an International Multi-institutional Analysis , 2011, Annals of Surgical Oncology.

[18]  John B Carlin,et al.  American Journal of Epidemiology Practice of Epidemiology Multiple Imputation for Missing Data: Fully Conditional Specification versus Multivariate Normal Imputation , 2022 .

[19]  M. Choti,et al.  Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis: An International Multi-Institutional Analysis of 1669 Patients , 2009, Annals of surgery.

[20]  F. Lévi,et al.  Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? , 2004, Annals of surgery.

[21]  Bernard Paule,et al.  Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival , 2004, Annals of surgery.

[22]  F. Kwiatkowski,et al.  Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.

[24]  K. Hatakeyama,et al.  Simultaneous detection of colorectal carcinoma liver and lung metastases does not warrant resection. , 2001, Journal of the American College of Surgeons.

[25]  A. Andriulli,et al.  Prospective evaluation of the diagnostic efficacy of CA 19-9 assay as a marker for gastrointestinal cancers. , 1986, Digestion.